Advanced International Journal for Research
E-ISSN: 3048-7641
•
Impact Factor: 9.11
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with AIJFR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 1
January-February 2026
Indexing Partners
“Pharmaceutical Exports from India: Empirical Evidence on Innovation, FDI, and Exchange Rate Effects”
| Author(s) | Mr. Raghavendra B Chippalakatti, Dr. B. H. Nagoor |
|---|---|
| Country | India |
| Abstract | This paper explores the connection between the growth rate of India's pharmaceutical exports over a year and various economic markers foreign direct investment (FDI) in pharmaceuticals, patent applications, and the exchange rate. With the use of annual data from 1995 to 2023, the investigation uses Ordinary Least Squares (OLS) estimation following stationarity confirmation via unit root tests. The results indicate that there is a statistically significant adverse effect of exchange rate volatility on export performance, whereas the FDI inflows and patent filings effects are statistically not significant. The results indicate that although macroeconomic stability in currency value is crucial to export growth, other variables such as FDI and innovation indicators are probably too short-term or will need complementary enabling policies to show their export contributions. The research makes a contribution to the literature by presenting empirical evidence on short-run dynamics among innovation, investment, and trade in India's pharmaceutical industry and presenting policy implications for improving global competitiveness. |
| Keywords | Pharmaceutical exports, Innovation, Patent filings, Foreign Direct Investment (FDI), Exchange rate volatility, Trade competitiveness. |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 1, January-February 2026 |
| Published On | 2026-01-18 |
| DOI | https://doi.org/10.63363/aijfr.2026.v07i01.2969 |
| Short DOI | https://doi.org/hbk6zz |
Share this

E-ISSN 3048-7641
CrossRef DOI is assigned to each research paper published in our journal.
AIJFR DOI prefix is
10.63363/aijfr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.